Sign in

You're signed outSign in or to get full access.

Investview (INVU)

--

Earnings summaries and quarterly performance for Investview.

Research analysts covering Investview.

Recent press releases and 8-K filings for INVU.

Investview, Inc. Faces Regulatory Action in Poland Over iGenius Operations
INVU
Legal Proceedings
Profit Warning
  • Investview, Inc. (INVU) received notice on December 29, 2025, that the Polish Office of Competition and Consumer Protection (UOKiK) issued a formal administrative decision regarding its iGenius business operations in Poland.
  • UOKiK concluded that certain aspects of the iGenius business model in Poland violate Polish laws prohibiting pyramid-style promotional schemes.
  • The decision imposes an administrative fine of PLN 14,668,589 (approximately USD $4 million) and includes a cease-and-desist order.
  • The Company disagrees with the conclusions and intends to appeal the decision, expecting to continue normal operations in Poland during the appeal process.
  • An unsuccessful appeal could lead to the imposition of the fine and a requirement to modify or discontinue iGenius operations in Poland, potentially having a materially adverse impact on the Company’s business, financial condition, results of operations, or prospects, given the significance of iGenius operations.
Jan 5, 2026, 10:27 PM
Investview Reports Q3 2025 Financial Results and Operational Highlights
INVU
Earnings
Share Buyback
New Projects/Investments
  • Investview, Inc. (INVU) reported a 22.9% decrease in Net Revenue to $9.1 million for the third quarter ended September 30, 2025, compared to the prior year, and a net loss of $0.9 million for the same period. For the nine months ended September 30, 2025, Net Revenue decreased 28.2% to $29.1 million, resulting in a net loss of $1.1 million.
  • As of September 30, 2025, cash and cash equivalents were $15.1 million, a 32.9% decrease from December 31, 2024, with $3.1 million in net cash used in operating activities for the nine-month period.
  • The company continued its share repurchase program, buying back over 10.2 million shares as of November 7, 2025, which reduced total shares outstanding by 0.55% since the beginning of 2025.
  • Key segment performance for Q3 2025 included iGenius with $7.1 million in net revenue, SAFETek with $0.92 million in net revenue and 7.87 Bitcoin produced, and Renu Labs contributing $1.1 million in net revenue.
  • Investview invested $1.25 million in Dream SPV VA LLC in October 2025 for an early-stage nuclear energy enterprise, and plans commercial launches for myLife Wellness and the Opencash app starting in Q4 2025.
Nov 13, 2025, 7:40 PM